FEMSA Grows Operating Income High Single Digit in 2Q13

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
FEMSA Grows Operating Income High Single Digit in 2Q13

MONTERREY, MEXICO--(Marketwired - Jul 25, 2013) - Fomento Económico Mexicano, S.A.B. de C.V. ("FEMSA") ( NYSE : FMX ) ( BMV : FEMSAUBD ) ( BMV : FEMSAUB ) announced today its operational and financial results for the second quarter of 2013.

Second Quarter 2013 Highlights:

  • FEMSA income from operations grew 9.1% compared to the second quarter of 2012, reflecting growth at Coca-Cola FEMSA and FEMSA Comercio. On an organic basis 1 income from operations grew 8.0%.
  • Coca-Cola FEMSA income from operations increased 9.1% compared to the second quarter of 2012, mainly driven by lower sugar prices combined with the appreciation of the Mexican peso as applied to Coca-Cola FEMSA's U.S. dollar-denominated raw material costs. On an organic basis 1 income from operations increased 7.6%.
  • FEMSA Comercio achieved total revenues growth of 11.7% and income from operations growth of 6.7% compared to the second quarter of 2012 , driven by 1,026 net new store openings in the last twelve months.

José Antonio Fernández Carbajal, Chairman and CEO of FEMSA, commented: "As is sometimes the case, our quarterly results include reasons to be optimistic, but also a few challenging areas. At Coca-Cola FEMSA, in spite of sluggish macro growth, again it was Mexico that provided the positive momentum on the back of improved profitability, driven by strong execution and a favorable raw material environment. Performance in South America remained muted, particularly in Brazil. And FEMSA Comercio had results that reflect tough comparisons, a soft consumer environment in Mexico, and some continued pressure from the telephony category. It is too soon to tell whether the second half will show a meaningful improvement, however the level of economic activity is expected to gradually increase and we are cautiously optimistic about the rest of the year. Most importantly, the long-term structural advantages across our businesses continue to strengthen and we will continue to execute our strategy and will keep investing to improve and expand our competitive position across our operations. On that note, during the quarter we closed the acquisitions of Farmacias Yza and Farmacias Moderna on the retail front in Mexico, and we announced the acquisition of Fluminense on the bottling front in Brazil. So we keep moving forward at a solid, steady pace."

To obtain the full text of this earnings release, please visit our Investor Relations website at www.femsa.com/investor under the Financial Reports section

This report may contain certain forward-looking statements concerning our future performance that should be considered as good faith estimates made by us. These forward-looking statements reflect management's expectations and are based upon currently available data. Actual results are subject to future events and uncertainties, which could materially impact our actual performance.

FEMSA is a leading company that participates in the beverage industry through Coca-Cola FEMSA, the largest franchise bottler of Coca-Cola products in the world; and in the beer industry, through its ownership of the second largest equity stake in Heineken, one of the world's leading brewers with operations in over 70 countries. In the retail industry it participates with FEMSA Comercio, operating various small-format chain stores, including OXXO, the largest and fastest-growing chain of stores in Latin America. All of which is supported by a Strategic Business area.

1 Excludes non-comparable results from Coca-Cola FEMSA acquisitions in the last twelve months.

Media Contact: (52) 81-8328-6046 Email Contact www.femsa.com Investor Contact: (52) 81-8328-6167 Email Contact www.femsa.com/investor

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 37

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 35

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 40

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing the P/E Ratio of Western Alliance: Insights and Trends

Updated Category News Views 123

Understanding the P/E Ratio of Western Alliance In the current market climate, Western Alliance Inc. (WAL) has seen its share price hit $79.17, reflecting a modest increase of 0.47%. Over the past month, however, the stock has experienced a decrease of 6.61%. Interestingly, despite this recent dip, when we look at the yearly perspective, the stock has climbed by 6.77%...

Continue Reading
Hesai Group Innovates Lidar Technology for Cadillac SUVs

Updated Category News Views 219

Hesai Group Powers Cadillac's VISTIQ with Advanced Lidar Technology Hesai Group, a prominent player in lidar technology, has achieved a significant milestone by partnering with SAIC-GM to integrate its advanced AT series lidar system into Cadillac's new all-electric VISTIQ SUV. This integration represents a breakthrough in automotive design and technology, as it is the...

Continue Reading
Jeffersonville Bancorp Reports Strong Q2 Earnings and Dividend

Updated Category News Views 121

Jeffersonville Bancorp Delivers Impressive Earnings for Q2 Jeffersonville Bancorp, Inc. (OTCQB - JFBC) reported robust second quarter results, showcasing a net income of $3,290,000, equivalent to $0.78 per share. This financial performance indicates a notable increase from the previous year's earnings of $3,031,000, or $0.72 per share, reflecting a significant rise in...

Continue Reading
SAS, NPower Team Up: Disrupting Tech Career Access

Updated Category News Views 12

An Unlikely Alliance Fueling Tech Careers Not every day do you see a big-name data firm strut their stuff in the nonprofit world. SAS has teamed up with NPower to flip the script on tech career access. This isn't just a side project—it's a full-throttle mission to drive hardcore data understanding into communities that have long been left hanging. Right here in Cary,...

Continue Reading
America's Emotional Landscape: Loneliness and Division Exposed

Updated Category News Views 216

Understanding the Impact of Societal Division on Emotional Health Most U.S. adults report feeling isolated, in need of more emotional support Loneliness and a sense of emotional disconnection are increasingly shaping the lifes of individuals in America. Recent findings reveal that a significant majority of U.S. adults feel stressed due to societal division. This insight...

Continue Reading